EFB Dengue Literature Review

CXCR3

5 min read

CXCR3

Overview

CXCR3 (CD183) is a chemokine receptor that mediates homing to sites of IFN-γ-driven inflammation. Its ligands — CXCL9, CXCL10 (IP-10), and CXCL11 — are IFN-γ-inducible chemokines produced at sites of active inflammation. In B cell biology, CXCR3 expression marks cells destined for inflammatory tissue rather than lymphoid follicles, positioning it as the functional counterpart to CXCR5 (which mediates follicular homing via CXCL13).

The CXCR5⁻/CXCR3⁺ chemokine receptor switch on extrafollicular B cell populations is a key functional signature distinguishing EF pathway cells from follicular/GC-derived populations.

Key Points from Literature

  • CXCR3 upregulated on EF populations in severe COVID-19: In CoV-A (EF-high) patients, aN and DN2 cells showed increased CXCR3 surface expression compared with follicular populations (rN and DN1). Concurrently, CXCR5 was decreased on these same populations. This reciprocal CXCR5↓/CXCR3↑ pattern is consistent with homing away from B cell follicles toward IFN-γ-inflamed peripheral tissues (see Woodruff2020 - EF B Cell Responses in COVID-19, spectral flow cytometry, n=9 CoV-A patients).

  • Included in 24-marker spectral flow cytometry panel: CXCR3 was part of the comprehensive homing marker set (alongside CXCR5, CXCR4, CD62L) used to characterise B cell migration potential in COVID-19 (see Woodruff2020 - EF B Cell Responses in COVID-19, Supplementary Table 1).

  • CXCL10 (IP-10) elevated in EF-high patients: Plasma CXCL10 was significantly elevated in CoV-A patients and correlated with CRP (r² = 0.58, P = 0.004). CXCL10 is both a CXCR3 ligand and an established biomarker of COVID-19 severity, linking the tissue-homing programme of EF B cells to the inflammatory milieu that drives their generation (see Woodruff2020 - EF B Cell Responses in COVID-19).

  • CXCR3 expressed on dengue acute-phase plasmablasts: Plasmablasts in acute dengue carry the phenotype CD20⁻CD38⁺⁺CD27⁺Ki67⁺CD71⁺CXCR3⁺, confirming that CXCR3 expression on EF-derived ASCs is not unique to COVID-19 but extends to dengue (see Ansari2025 - Peripheral T Helper Subset Drives B Cell Response in Dengue, multi-color FCM, n=170 dengue cohort).

  • CXCR3 measured by CITE-seq on alternative lineage B cells: CITE-seq surface protein measurement confirmed CXCR3 expression on alternative lineage (atBC) populations in both malaria-exposed and non-exposed donors, consistent with the CXCR5⁻/CXCR3⁺ homing switch seen on EF pathway cells in COVID-19 and dengue (see Sutton2021 - Alternative Lineage B Cells in Vaccination and Infection, n=4, CITE-seq).

  • CXCR3 is listed among the defining surface markers of human atypical B cells. Human ABCs “often express the transcription factor T-bet along with distinct surface markers, including CD11c, CXCR3, FCRL4, and FCRL5” (see Glaros2025 - Multilayered Identity of B Cell Memory, review, no original data). This places CXCR3 in the review-level ABC marker set alongside the markers this wiki already tracks — relevant because CXCR3 is already documented on dengue plasmablasts.

  • CXCR3 mediates recruitment of resident memory B cells to infected tissue — including antigen-irrelevant ones. In the lung, B resident memory cells of diverse specificities, including those unrelated to the invading pathogen, are rapidly recruited to the infection site via an alveolar-macrophage-initiated cascade: IFN-γ from NK cells → CXCL9/CXCL10 → recruitment of CXCR3-expressing memory B cells. Some of these differentiate into plasma cells on innate signals alone, without specificity for the current threat (see Glaros2025 - Multilayered Identity of B Cell Memory, review, mouse). See Tissue-Resident Memory B Cell. Lung BRMs also express CCR6 alongside CXCR3.

  • ★ CXCR3 is a functional T-bet target in B cells, confirmed by inducible deletion. Tamoxifen-induced deletion of Tbx21 from established day-90 influenza memory B cells (Tbx21^fl/fl^hCD20-TAM-cre) significantly reduced CXCR3 expression on total B cells and on NP⁺ memory B cells, while CXCR3 on T cells was unaffected — an internal specificity control for the B-cell-restricted deletion (see Stone2019 - T-bet Promotes ASC Differentiation by Limiting IFN-gamma Inflammation, mouse, n=3–6/group). This is direct genetic evidence for the T-bet → CXCR3 link that the wiki previously held on correlative grounds. Note the same experiment cut NP⁺ ASC recall ~10-fold without changing memory B cell numbers, so loss of CXCR3 tracks with loss of differentiation capacity, not loss of the memory pool — see Memory B Cell, T-bet.

  • CXCR3 is highly expressed on murine T-bet⁺CD11c⁺ B cells, and is one of the authors’ candidate explanations for a knockout that failed in vivo. CXCR3 transcript was higher on T-bet⁺CD11c⁺ cells than on naive follicular or GC B cells as the population relocated to the marginal zone. When S1pr3⁻/⁻ cells showed no competitive disadvantage at day 15 in mixed bone marrow chimeras — despite S1PR3 being required for S1P chemotaxis in vitro, where TY52156 abolished migration — the authors proposed compensation by Cnr2 and CXCR3, and stated explicitly that “this was not further investigated” (see Song2022 - Tfh Outside Germinal Centers Drive T-bet CD11c B Cells, mouse, LCMV-Armstrong, n=3–5 mice/group). Treat the CXCR3 retention role as a hypothesis, not a result.

Contradictions & Debates

  • Whether CXCR3 expression on EF B cells reflects functional tissue homing or is simply a marker of IFN-γ exposure without homing consequence has not been directly tested in humans. The murine literature supports functional CXCR3-mediated B cell homing to inflamed tissues, but human in vivo trafficking data are lacking.

CXCR5, DN2 B Cell, Activated Naive B Cell, Extrafollicular Response, T-bet, CD11c, Plasmablast, CD71, Atypical B Cell, Tissue-Resident Memory B Cell, Age-Associated B Cell

Sources

Graph View

Backlinks